T. Rowe Price Associates’s Stereotaxis STXS Stock Holding History
Bought
Maintained
Sold
Other funds holding STXS
DCM
LIM
APCM
EIM
ACM
WAM
T. Rowe Price Associates's STXS Position: Q2 2026 in Review
T. Rowe Price Associates increased its Stereotaxis (STXS) stake by 20% in Q2 2026, buying an estimated $44.6K and bringing the position to 140,702 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #2944.
T. Rowe Price Associates first reported a position in STXS in Q1 2021 and has held it in 22 quarters since. The position peaked at $265K in Q3 2025. 108 funds tracked by Wall St. Rank hold STXS as of Q2 2026.
- T. Rowe Price Associates held 140,702 shares of Stereotaxis worth $243K as of Q2 2026.
- T. Rowe Price Associates bought 23,781 Stereotaxis shares in Q2 2026, an estimated $44.6K.
- Stereotaxis made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2944 holding.
- T. Rowe Price Associates first reported a position in Stereotaxis in Q1 2021 and has held it in 22 quarters since.
- T. Rowe Price Associates's Stereotaxis position peaked at $265K in Q3 2025.
- 108 funds tracked by Wall St. Rank held Stereotaxis as of Q2 2026.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.